Table 1.
Variable | AD-P, N=367 | AD+P, N=256 | df | p value* |
---|---|---|---|---|
Follow-up, years | 2.5 (3.6) | 3.3 (3.1) | 595 | 0.003 |
Baseline MMSE | 21.8 (4.5) | 20.5 (5.3) | 490 | <0.001 |
Age at baseline | 76.9 (6.9) | 76.6 (6.4) | 576 | 0.54 |
Sex | ||||
female | 214 (58 %) | 164 (64 %) | 1 | 0.15 |
male | 153 (42 %) | 92 (36 %) | ||
Race | ||||
Asian | 2(1%) | 0(0%) | 2 | 0.48 |
African-American | 23 (6 %) | 20 (8 %) | ||
Caucasian | 342 (93 %) | 236 (92 %) | ||
Number of drugs taken | 9.7 (4.5) | 8.6 (4) | 587 | 0.002 |
Education, years | ||||
<12 | 162 (44 %) | 152 (59 %) | 1 | <0.001 |
>=12 | 205 (56 %) | 104 (41 %) |
AD-P: Alzheimer Disease without psychosis; AD+P: Alzheimer disease with psychosis; MMSE:
Mini-mental State Examination.
Results for AD-P and AD+P are mean (SD) for continuous variables and total (%) for categorical variables.
T-test for continuous variables (Follow-up, years; Baseline MMSE, Age at baseline), Chi-square test for sex and education, and Fisher exact test for race.